Glucose Health, Inc. balance sheet GLUC

Annual Quarterly

As of Sep 30, 2017, Glucose Health, Inc. had total assets of $26,353 and total liabilities of $452,585. Total assets were down 40.1% from a year earlier. Stockholders' equity was negative, at -$426,232, because liabilities exceed assets. Cash and investments were $16,636. The current ratio, current assets divided by current liabilities, was 0.06.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

Line	FY 2017 Sep 30, 2017	FY 2016 Dec 31, 2016	FY 2015 Dec 31, 2015	FY 2014 Dec 31, 2014	FY 2013 Dec 31, 2013	FY 2012 Dec 31, 2012	FY 2011 Dec 31, 2011
Assets
Cash	0 +709.5%	0 +899.6%	0 +189.0%	—	0 +767.1%	0	0
Cash and investments	0 +709.5%	0 +899.6%	0 +189.0%	—	0 +767.1%	0	0
Receivables	0 -22.5%	0 +272.2%	0	—	—	—	—
Inventory	0 -100.0%	—	0	0 -100.0%	0	—	—
Total current assets	0 -40.1%	0 +117.8%	0 -65.5%	0 +70.9%	0 +2278.3%	0 -96.0%	0
Total assets	0 -40.1%	0 +115.1%	0 -65.0%	0 +72.1%	0 -87.7%	0 -11.1%	0
Liabilities and equity
Total current liabilities	0 +8.4%	1 +31.1%	0 +24.2%	0 +45.3%	0 +20.4%	0 -55.8%	0
Total liabilities	0 +8.4%	1 +31.1%	0 +24.2%	0 +45.3%	0 +20.4%	0 -55.8%	0
Stockholders' equity	-0 -14.1%	-0 -27.8%	-0 -38.2%	-0 -41.9%	-0 -990.8%	0 +111.9%	-0
Ratios
Current ratio	0.06x	0.06x	0.04x	0.13x	0.11x	0.01x	0.06x
Return on equity	—	—	—	—	—	-1,797.65%	—
Return on assets	-322.78%	-1,238.33%	-1,726.90%	-1,520.35%	-5,702.02%	-192.16%	-384.79%
Book value per share	-0.09	-0.15	-0.16	-0.21	-0.52	0.00	-0.00

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.

Company profile

Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as: GLUC (OTC)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Bentonville, AR
SEC filer status: Smaller reporting company
SEC CIK: 1420108
Former names: Bio-Solutions Corp. (until Dec 16, 2014)

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.